A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients
Clinical Pharmacology: Advances and Applications · 2016
DOI: 10.2147/cpaa.s106676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology: Advances and Applications, 2016. Verfasst von Mervyn Mer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Divisions of Critical Care and Pulmonology, University of the Witwatersrand, Johannesburg, South Africa. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Divisions of Critical Care and Pulmonology, University of the Witwatersrand, Johannesburg, South Africa.
- Office of the Dean, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Scientific Affairs Department, Triclinium Clinical Development (Pty) Ltd, Centurion, South Africa.
Zitieren
APA
Mer, M., Snyman, J. R., van Rensburg, C. E., van Tonder, J. J., & Laurens, I. (2016). A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients. Clinical Pharmacology: Advances and Applications. https://doi.org/10.2147/cpaa.s106676
Vancouver
Mer M, Snyman JR, van Rensburg CE, van Tonder JJ, Laurens I. A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients. Clinical Pharmacology: Advances and Applications. 2016. doi:10.2147/cpaa.s106676
BibTeX
@article{Mer2016,
author = {Mer, Mervyn and Snyman, Jacques Rene and van Rensburg, Constance Elizabeth Jansen and van Tonder, Jacob John and Laurens, Ilze},
title = {A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients},
journal = {Clinical Pharmacology: Advances and Applications},
year = {2016},
doi = {10.2147/cpaa.s106676}
}
EUVIMED